InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Mineralys Therapeutics, Inc.

MLYS Clue Score35
United States Fiscal year ends December CIK 0001933414 Results filed 4 Nov 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

8
Insider
Date
Role
Action
Shares
Price
Amount
Brian Taylor Slingsby
22 Sep 2026
Director
Sell indirect
104,320
$28.81
$3.01M
Brian Taylor Slingsby
20 Nov 2025
Director
Sell indirect
1,000,000
$43.35
$43.35M
Jon Congleton
11 Nov 2025
Chief Executive Officer
Sell
32,850
$46.89
$1.54M
Jon Congleton
11 Nov 2025
Chief Executive Officer
Sell
112,275
$45.83
$5.15M
Jon Congleton
11 Nov 2025
Chief Executive Officer
Sell
29,207
$45.20
$1.32M
Jon Congleton
11 Nov 2025
Chief Executive Officer
Sell
4,000
$43.50
$173.98K
Jon Congleton
11 Nov 2025
Chief Executive Officer
Sell
8,862
$42.31
$374.95K
Jon Congleton
11 Nov 2025
Chief Executive Officer
Sell
12,806
$41.64
$533.24K
Show all 83 transactions →

What was left out

Form 4 filings counted 56
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 3
Sales on a Rule 10b5-1 plan 14
Sales straight out of an exercise 58
Sales at will 8
Transactions with no price 0
Shares from compensation/vesting 1,088,447
History held since 13 Feb 2023